貴州三力(603439.SH):“GMP改造二期擴建項目”預計6月可完成全部生產線的安裝
格隆匯1月2日丨貴州三力(603439.SH)公佈,連日來,隨着新冠肺炎疫情防控新十條措施、對新型冠狀病毒感染實施“乙類乙管”等方案相繼出台,國內對新型冠狀病毒感染治療相關藥品的需求大幅提升。針對公司開喉劍噴霧劑及開喉劍噴霧劑(兒童型)供應緊張的情況,公司積極響應政府的號召,努力供應國內各醫院端、OTC端及基層醫療機構,嚴格落實生產規範及安全生產防範措施,加緊作業,執行車間機器不停轉、員工輪崗、7*24小時的生產計劃,目前產能利用率接近200%,可保障每天超過20萬瓶開喉劍系列產品的生產和供應。
公司首次公開發行募集資金淨額23684.10萬元。其中“GMP改造二期擴建項目”預計總投資額為16432萬元,在變更項目建設地點及主要建設內容後,預計總投資額為22000萬元。公司募投項目“GMP改造二期擴建項目”已在公司新取得的毗鄰公司現廠區的土地持續建設中,截至目前,項目已完成2棟4層主體生產車間的建設工作,並將於2023年1月中旬開始淨化工程的實施,預計6月可完成全部生產線的安裝,7月完成調試並開展試生產工作,屆時新增產能規模預計將達到開喉劍噴霧劑6000萬瓶/年,公司總體產能規模將接近10000萬瓶/年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.